We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$823M
AUM Growth
+$71.1M
(+9.5%)
Cap. Flow
+$54.2M
Cap. Flow
% of AUM
6.59%
Top 10 Holdings %
Top 10 Hldgs %
50.09%
Holding
190
New
61
Increased
39
Reduced
31
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$19.1M |
| 2 |
Macerich
MAC
|
+$12.1M |
| 3 |
EVA
Enviva Inc.
EVA
|
+$9.8M |
| 4 |
Okta
OKTA
|
+$8.15M |
| 5 |
PEGI
Pattern Energy Group Inc. Class A
PEGI
|
+$7.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rithm Capital
RITM
|
+$19.4M |
| 2 |
Zimmer Biomet
ZBH
|
+$12.9M |
| 3 |
Oracle
ORCL
|
+$12.8M |
| 4 |
United Rentals
URI
|
+$10.4M |
| 5 |
CIO
City Office REIT
CIO
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.81% |
| 2 | Technology | 10.73% |
| 3 | Utilities | 6.45% |
| 4 | Materials | 4.95% |
| 5 | Energy | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
76
DELISTED
Aetna Inc
AET
| $905K | 0.11% |
5,000
-2,000
| -29% | -$344K |
|
77
BioMarin Pharmaceuticals
BMRN
$11.9B
| $892K | 0.11% |
10,000
+3,000
| +43% | +$261K |
|
78
Amazon
AMZN
$2.47T
| $878K | 0.11% |
15,000
-25,300
| -63% | -$1.39M |
|
|
NGD
79
CALL
DELISTED
New Gold Inc
NGD
| $823K | 0.1% |
+250,000
| New | +$839K |
|
80
PUT
Sunrun
RUN
$2.25B
| $807K | 0.1% |
+136,800
| New | +$786K |
|
81
Micron Technology
MU
$878B
| $740K | 0.09% |
+18,000
| New | +$775K |
|
|
VXX
82
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $697K | 0.08% |
+25,000
| New | +$825K |
|
83
Cisco
CSCO
$453B
| $689K | 0.08% |
+18,000
| New | +$643K |
|
84
Workday
WDAY
$41.7B
| $661K | 0.08% |
+6,500
| New | +$694K |
|
85
NETGEAR
NTGR
$617M
| $646K | 0.08% |
+11,000
| New | +$563K |
|
86
Abeona Therapeutics
ABEO
$341M
| $634K | 0.08% |
1,600
-400
| -20% | -$165K |
|
87
Eli Lilly
LLY
$1.09T
| $634K | 0.08% |
+7,500
| New | +$638K |
|
|
ORBC
88
DELISTED
ORBCOMM, Inc.
ORBC
| $611K | 0.07% |
+60,000
| New | +$634K |
|
89
Supernus Pharmaceuticals
SUPN
$2.73B
| $598K | 0.07% |
+15,000
| New | +$593K |
|
90
Universal Health Services
UHS
$10.2B
| $567K | 0.07% |
+5,000
| New | +$534K |
|
91
CVS Health
CVS
$137B
| $545K | 0.07% |
+7,500
| New | +$545K |
|
92
Boston Scientific
BSX
$68.7B
| $496K | 0.06% |
+20,000
| New | +$552K |
|
|
BOLD
93
DELISTED
Audentes Therapeutics, Inc
BOLD
| $471K | 0.06% |
15,072
-10,000
| -40% | -$275K |
|
94
McKesson
MCK
$105B
| $468K | 0.06% |
+3,000
| New | +$444K |
|
|
MULE
95
DELISTED
MuleSoft, Inc.
MULE
| $465K | 0.06% |
+20,000
| New | +$453K |
|
96
Voyager Therapeutics
VYGR
$184M
| $415K | 0.05% |
+25,000
| New | +$429K |
|
97
Advanced Micro Devices
AMD
$703B
| $411K | 0.05% |
40,000
+30,000
| +300% | +$351K |
|
98
Medtronic
MDT
$113B
| $404K | 0.05% |
+5,000
| New | +$400K |
|
|
MLNX
99
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $388K | 0.05% |
+6,000
| New | +$317K |
|
100
Exelixis
EXEL
$14B
| $380K | 0.05% |
+12,500
| New | +$333K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Ardsley Advisory Partners held 190 positions worth $823M, up 9.5% from $752M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Ardsley Advisory Partners deployed $54.2M of net new capital in Q4 2017, opening 61 new positions and adding to 39 existing holdings. Its largest new stake was Macerich: 198,500 shares worth $13M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was PARSLEY ENERGY INC, an estimated $9.35M trimmed.
- Ardsley Advisory Partners's largest Q4 2017 buy was Macerich: 198,500 shares worth $13M.
- Ardsley Advisory Partners added most to AbbVie in Q4 2017, an estimated $19.1M increase.
- Ardsley Advisory Partners's biggest Q4 2017 reduction was PARSLEY ENERGY INC, cutting an estimated $9.35M.
- Ardsley Advisory Partners fully exited Rithm Capital in Q4 2017, selling an estimated $19.4M.
- Ardsley Advisory Partners's ten largest holdings make up 50% of its $823M portfolio in Q4 2017.
- Ardsley Advisory Partners opened 61 new positions and closed 53 in Q4 2017.
- Ardsley Advisory Partners's portfolio value rose 9.5% quarter-over-quarter to $823M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2017, filed 14 Feb 2018.